Aref Ghanaatpisheh: The Role of Systemic Inflammation in Preoperative Deep Vein Thrombosis Risk Assessment
Aref Ghanaatpisheh, Reviewer at European Heart Journal, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Thrombosis Journal, adding:
“Can a simple blood-based inflammatory marker help identify patients at risk of preoperative deep vein thrombosis (DVT)?
We are pleased to share our systematic review and meta-analysis investigating the diagnostic potential of the Systemic Immune-Inflammation Index (SII) in predicting preoperative DVT.
Key findings:
- Five retrospective cohort studies involving 4,097 patients were included.
- The pooled area under the curve (AUC) was 0.671.
- Pooled sensitivity was 59.1%, while specificity reached 78.0%.
- SII demonstrated potential as an adjunctive biomarker for preoperative DVT risk stratification.
Clinical significance:
Although SII shows promise as an accessible and inexpensive biomarker, it should not be considered a standalone diagnostic or screening tool.
Further prospective, multicenter studies are needed to validate its clinical utility and establish population-specific thresholds.
This research highlights the importance of understanding the interplay between systemic inflammation and thrombosis and exploring accessible biomarkers that may complement existing clinical risk assessment strategies.”
Title: Systemic immune-inflammation index for predicting pre-operative deep vein thrombosis: a systematic review and meta-analysis
Authors: Sepehr Ramezanipour, Aref Ghanaatpisheh, Seyed Hesam Hojjat, Zahra Azizi, Omid Salimi, Alireza Amini, Mohammad Ali Nazari

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 21, 2026, 03:43Dimitrios Hatzichristou: Advancing Standardization and Quality Control in Platelet-Rich Plasma Therapy
-
Nov 21, 2026, 03:15Amirabbas Sheykhalo: Silent Mesenteric Ischemia in Portomesenteric Thrombosis
-
Nov 21, 2026, 02:51Ivone Su: Raising Awareness of Venous Thromboembolism
-
Nov 21, 2026, 02:40Aniqa Gohar: One Heart Conclave – Advancing Integrated Thrombosis Care
-
Nov 20, 2026, 17:27Adam Bryant: Great Science, Valuable Connections and a Wonderful Haematology Community at Blood 2026
-
Nov 20, 2026, 17:25Gurpreet Kaurr: Scientific Discussions, New Perspectives and Inspiration at HAEMATOCON 2026
-
Nov 20, 2026, 17:24Bispecific FVIIIa-Mimetic Antibodies in Haemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Nov 20, 2026, 17:23Khalid Rehman: Psychosocial Burden Among Caregivers of Patients with Beta-Thalassemia Major in Pakistan
-
Nov 20, 2026, 17:20Dhinesh Selvaraju: Caplacizumab Becomes the First FDA-Approved Treatment for Pediatric aTTP